ArticleJournal of child & adolescent trauma2025
Adversity, Trauma Symptoms and the Effectiveness of an Australian Individualised Developmental Trauma Intervention Program.
Article in Journal of child & adolescent trauma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the effectiveness of a therapeutic intervention program Take Two; designed to address developmental trauma experienced by Child Protection clients in Victoria, Australia. Replicating a 2010 evaluation study of the program, we utilised a Time 1-Time 2 design to identify the impact of tailored Take Two treatments informed by the Neurosequential Model of Therapeutics' (NMT™). Change in the overall sample was measured by the Trauma Symptom Checklist for Children (TSCC; ages 8-16 years) and Trauma Symptom Checklist for Young Children (TSCYC; ages 3-12 years). In addition, a sub-cohort of children with severe adverse infant experiences was identified using a developmental history of adversity tool; Part A of the Neurosequential Network's Neurosequential Model of Therapeutics (NMT™) Metric. Treatment effects were also evaluated to determine the extent to which this potentially more vulnerable subgroup was improving. Significant improvement was found in the TSCC cohort (8-16 years) with effect sizes ranging from small to medium (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.